ID

14928

Description

This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Check for Study Continuation

Mots-clés

Versions (1)
  1. 08/05/2016 08/05/2016 -
Téléchargé le

8 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Check for Study Continuation Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396

Anglais

Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 Formulaires  
Identification
Description

Identification

Alias
UMLS CUI-1
C1300638
Center number
Description

Center number

Type de données

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0805701
Subject ID
Description

Subject ID

Type de données

text

Alias
UMLS CUI [1]
C2348585
Treatment Number
Description

Treatment Number

Type de données

text

Alias
UMLS CUI [1]
C1522541
Visit Number
Description

Visit Number

Type de données

integer

Alias
UMLS CUI [1]
C0545082
Check for Study Continuation
Description

Check for Study Continuation

Did the subject return for visit 2
Description

Yes, Please complete the next pages No, Please tick the ONE most appropriate reason and skip the following pages of this visit.

Type de données

boolean

Alias
UMLS CUI [1]
C2827364
most appropriate reason
Description

If Serious adverse event - Please complete and submit SAE report - Please specify SAE No. If Non-Serious adverse event - Please complete Non-serious Adverse Event section - Please specify AE No. or solicited AE code If Other, please specify (e.g.: consent withdrawal, Protocol violation, ... )

Type de données

text

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0392360
Code of SAE,AE or solicited AE
Description

Code of SAE,AE,solicited AE or specification

Type de données

text

Alias
UMLS CUI [1]
C0877248
Who made the decision
Description

Who made the decision

Type de données

text

Alias
UMLS CUI [1]
C1389424
Laboratory Tests:Blood Sample
Description

Laboratory Tests:Blood Sample

Has a Blood Sample been taken
Description

Blood Sample

Type de données

boolean

Alias
UMLS CUI [1]
C0005834
Date of sample
Description

Only fill in if different from visit date

Type de données

date

Alias
UMLS CUI [1]
C0460065
Retour au début de la page

Similar models

Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Identification
C1300638 (UMLS CUI-1)
Center number
Item
Center number
text
C1301943 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Treatment Number
Item
Treatment Number
text
C1522541 (UMLS CUI [1])
Item
Visit Number
integer
C0545082 (UMLS CUI [1])
Visit Number
Code List
Visit Number
CL Item
1 (1)
CL Item
2 (2)
Item Group
Check for Study Continuation
Did the subject return for visit 2
Item
Did the subject return for visit 2
boolean
C2827364 (UMLS CUI [1])
Item
most appropriate reason
text
C0679823 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
most appropriate reason for Absence
Code List
most appropriate reason
CL Item
Serious adverse event (SAE)
CL Item
Non-Serious adverse event (AEX)
CL Item
Other (OTH)
Code of SAE,AE,solicited AE or specification
Item
Code of SAE,AE or solicited AE
text
C0877248 (UMLS CUI [1])
Item
Who made the decision
text
C1389424 (UMLS CUI [1])
Who made the decision:
Code List
Who made the decision
CL Item
Investigator (I)
CL Item
Parents/Guardians (P)
Blood Sample
Item
Has a Blood Sample been taken
boolean
C0005834 (UMLS CUI [1])
Date of sample
Item
Date of sample
date
C0460065 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial